Target intelligence / Profile preview

GLI family zinc finger 1 mRNA 3'-untranslated region (GLI1 mRNA 3'-UTR) (GLI1 mRNA 3'-UTR)

Target
GLI1 mRNA 3'-UTR
Molecular classification
Transcription factor, Other
01

Overview

The GLI family zinc finger 1 (GLI1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory sequence located at the 3' end of the GLI1 transcript, which encodes the primary transcriptional activator of the Hedgehog (Hh) signaling pathway (UniProt P08151). This region serves as a scaffold for various microRNAs, such as miR-324-5p and miR-133b, and RNA-binding proteins that modulate the stability and translation of the mRNA (Ferretti et al., 2008, Nature Genetics). In many cancers, including medulloblastoma and basal cell carcinoma, the GLI1 3'-UTR is involved in the dysregulation of Hh signaling, often through the loss of microRNA-mediated suppression, leading to overexpression of the GLI1 protein and subsequent tumor growth (PubMed: 18469814). As a therapeutic target, the GLI1 mRNA is targeted by RNA-based therapies such as the antisense oligonucleotide ISIS 183750 (IONIS-GLI1Rx), which was developed to reduce GLI1 levels by inducing mRNA degradation. These approaches are particularly valuable for treating tumors that have developed resistance to upstream Hh pathway inhibitors like vismodegib, which target the Smoothened (SMO) receptor. By directly targeting the mRNA of the terminal effector, these strategies provide a more direct method of pathway inhibition in GLI-dependent malignancies.

Other names
GLI1 3'-UTRGLI1 3' untranslated regionGLI1 mRNA 3' UTRGLI family zinc finger 1 3'-UTR
02

Mechanism of action

Antisense-mediated degradation of GLI1 mRNA via RNase H recruitment or RNA interference (RNAi) to suppress GLI1 protein synthesis.

03

Biological functions

Regulation of gene expressionmRNA stability controlTranslation regulationHedgehog signaling pathway modulation
04

Disease associations

CancerMedulloblastomaBasal cell carcinomaGlioblastomaPancreatic adenocarcinoma
05

Safety considerations

Off-target hybridizationDelivery to the central nervous systemImmunogenicity of RNA-based drugs
06

Interacting drugs

ISIS 183750 (IONIS-GLI1Rx)

3 more in the full profile.

07

Biomarkers

GLI1 mRNA expression levelsPTCH1 mRNA levelsHedgehog pathway activity

Beyond the preview

Go deeper on GLI family zinc finger 1 mRNA 3'-untranslated region (GLI1 mRNA 3'-UTR) (GLI1 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GLI family zinc finger 1 mRNA 3'-untranslated region (GLI1 mRNA 3'-UTR) (GLI1 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call